Colon Cancer
📧 Sign up to get email alerts when something new happens for Colon Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of Cancer [NA]
Clinical trial exploring the impact of ultra-processed food consumption on people at high risk of cancer; recruitment has not yet started.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Pain Evaluation Across Robotic and Laparoscopic Surgery for Colorectal Procedures
A clinical trial assessing pain outcomes in robotic versus laparoscopic surgery for colorectal procedures is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: First-in-Human Study of ATX-559, an Oral Inhibitor of DHX9, in Patients With Advanced or Metastatic Solid Tumors, and Molecularly Defined Cancers [Phase 1]
The first-in-human Phase 1 study of ATX-559, an oral DHX9 inhibitor from Accent Therapeutics, has been terminated; the trial included patien…
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: Pilot Study of Individualized Comprehensive Rehabilitation in Patients With Colorectal Cancer [NA]
A pilot study evaluating individualized comprehensive rehabilitation for colorectal cancer patients has completed; no results are provided i…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Exploration of Circulating microRNAs as Biomarkers of Chemo-induced Peripheral Neuropathy: a Study in Cancer Patients [NA]
This clinical trial investigates circulating microRNAs as biomarkers for chemotherapy-induced peripheral neuropathy in cancer patients and i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Quality Of Life In Colorectal Cancer Survivors [NA]
A clinical trial assessing quality of life in colorectal cancer survivors is currently recruiting at the Institute of Oncology Ljubljana.
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the safety and efficacy of a mesothelin-targeting logic-gated CAR T therapy in adults with solid tumors …
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Neoadjuvant Immunotherapy and Organ-sparing Treatment in Patients With Stage I-III dMMR Colon Cancer [Phase 2]
Phase 2 trial update on neoadjuvant pembrolizumab for organ-sparing treatment in patients with mismatch repair-deficient colorectal/colon ca…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Clinical trial evaluating circulating tumor DNA as an early biomarker to assess treatment response across multiple solid tumors; currently r…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Oncology, Undernutrition and Sensoriality: Links, Mechanisms and Levers for Action
A clinical trial update describing an oncology study investigating the connections between undernutrition and sensorial changes (taste/smell…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors. [EARLY_Phase 1]
An early-phase, open-label, single-arm trial evaluating KT032 cell injections for safety, tolerability, pharmacokinetics, and preliminary ef…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial [NA]
This update describes a single-center, open-label randomized trial comparing neoadjuvant CAPEOX chemotherapy to upfront surgery for locally …
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Phase II Study of Neoadjuvant Dostarlimab in Patients With Untreated T3-4N0-2 or Stage III pMMR/MSS Resectable Colon Cancer [Phase 2]
Phase II neoadjuvant trial of dostarlimab in untreated, resectable Stage III colon cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Early Commencement of Adjuvant Chemotherapy for Colon Cancer [Phase 3]
Phase 3 trial evaluating the early start of adjuvant chemotherapy for colon cancer; the study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Neoadjuvant FOLFOX Chemotherapy for Patients With Locally Advanced Colon Cancer [Phase 3]
Phase 3 neoadjuvant trial of the FOLFOX chemotherapy regimen for locally advanced colon cancer; the study is currently active but not recrui…
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study [Phase 2]
Phase 2 results of the TABAsCO study evaluating TAS-102 in combination with irinotecan and bevacizumab for pre-treated metastatic or unresec…
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual Disease [NA]
A completed clinical trial from MD Anderson evaluating a lifestyle intervention that combines vitamin D, aspirin, exercise, and a low-satura…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Neoadjuvant Chemotherapy for Obstructive Colon cancER First Treated by cOlostomy [Phase 3]
A Phase 3 clinical trial is evaluating neoadjuvant chemotherapy for obstructive colon cancer in patients first treated with a colostomy; rec…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Comparison Between Results of 2 Laparoscopic Surgical Procedures in Operable Colon Cancer Cases in Upper Egypt [NA]
A completed clinical trial from Sohag University comparing two laparoscopic surgical procedures for operable colon cancer (stages I–II) in U…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Effect of Perioperative Intravenous Infusion of Lidocaine on the Postoperative Course and the Immune Response in Patients Undergoing Surgery for Colon Cancer - the PILDI Study [Phase 2]
A Phase 2 clinical trial (PILDI Study) is investigating whether perioperative intravenous lidocaine improves postoperative recovery and modu…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Improving Care for Rural Patients With Solid Tumors [NA]
Clinical trial update from University of Colorado focusing on improving care for rural patients with solid tumors; the study is currently re…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic Testing [NA]
This clinical trial update describes evaluating a digital application designed to scale oncologist-initiated genetic testing across multiple…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Cemiplimab With Fianlimab for Resectable Non-Metastatic Colon Cancer [Phase 2]
A Phase 2 trial is evaluating cemiplimab in combination with fianlimab for patients with resectable non-metastatic colon cancer; the study i…
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients [Phase 2]
A Phase 2 trial investigating circulating tumor DNA–guided intensification of postoperative therapy in resected colon cancer has been suspen…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: A Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer [Phase 3]
Phase 3 multicenter study evaluating OncoVax, an active specific immunotherapy, in patients with stage II colon cancer. The trial status is …